(Q45412610)

14 December 2017

title

Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine (English)

1 reference

14 December 2017

5

Babiuk LA

1 reference

Sylvia van Drunen Littel-van den Hurk

14 December 2017

4

object named as

van Drunen Littel-van den Hurk S

1 reference

14 December 2017

Lopez AM

1

1 reference

14 December 2017

Hecker R

2

1 reference

14 December 2017

Mutwiri G

3

1 reference

14 December 2017

Townsend HG

6

1 reference

14 December 2017

language of work or name

1 reference

6 September 2006

1 reference

Veterinary Immunology and Immunopathology

14 December 2017

published in

1 reference

14 December 2017

volume

114

1 reference

14 December 2017

issue

1-2

1 reference

14 December 2017

page(s)

103-110

1 reference

In ovo administration of CpG oligodeoxynucleotides and the recombinant microneme protein MIC2 protects against Eimeria infections

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Current perspectives on control of equine influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Safety and efficacy of CpG-containing oligodeoxynucleotides as immunological adjuvants in rabbits*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Immunotherapeutic uses of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG motifs in bacterial DNA and their immune effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

The development of live attenuated cold-adapted influenza virus vaccine for humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

The effect of changing single radial hemolysis assay method when quantifying influenza A antibodies in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Biological activity of immunostimulatory CpG DNA motifs in domestic animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalin-inactivated or commercial killed bovine respiratory syncytial virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG-containing oligodeoxynucleotides augment and switch the immune responses of cattle to bovine herpesvirus-1 glycoprotein D

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Immunostimulatory DNA activates production of type I interferons and interleukin-6 in equine peripheral blood mononuclear cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

Derivation and characterization of a live attenuated equine influenza vaccine virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2006.07.013

10.1016/J.VETIMM.2006.07.013

7 January 2021

Identifiers

DOI

1 reference

release_nhwsynygyzcitovfyjs6je3cju

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nhwsynygyzcitovfyjs6je3cju

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference